We recently treated a 65 year old man with a 5 year history of progressive Alzheimer's Disease who developed persistent bradycardia whilst receiving a course of fluoxetine 20 mg daily for an episode of depression. He had no history or evidence of cardiac disease. 4 Hussein, 19945) . Fisch (1985) 6 in a retrospective ECG study showed that there was an association between fluoxetine and bradycardia but this effect was not noted in the elderly cohort. Many of the reported cases were receiving 40-80 mg of fluoxetine daily for treatment of depressive disorder and were noted to have had a history of heart disease or syncopal episodes. The mechanisms proposed in the literature relate to the effect of increased central nervous system serotonin on the medullary regulation of cardiovascular function (Ellison J M, 19902) and to the reported direct inhibition of oxidative metabolism by fluoxetine which may permit drug interaction (McAnally LE, 19924). The case we report was treated with 20 mg fluoxetine throughout his episode. He had no history or evidence of cardiac disease, and at no time was he hypotensive or subject to syncope. His pulse rate increased 12-14 days after discontinuation of the drug suggesting a direct association.
We have performed a literature search regarding the possible role of haloperidol in the bradycardia but no such association has been reported. Fluoxetine should be considered a possible cause of sinus bradycardia in the elderly in the absence of cardiac disease and when given in normal doses.
